stockrowAgilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
- Revenue
- +8.06%
- EPS
- +8.47%
- Free cash flow
- +69.5%
- Total debt
- +8.81%
Quarter to July 2026, against a year earlier
Follow A
Alert me
Agilent Technologies, Inc. (A) Operating cash flow
Agilent Technologies, Inc.'s operating cash flow for fiscal 2025 was $1.6B, down 11.0% from $1.8B in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.6B. Over the past ten years it has ranged from $512.0M (fiscal 2015) to $1.8B (fiscal 2023); the current reading is higher than 82% of that period. Agilent Technologies, Inc. ranks 6th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.6B | (10.97%) |
| FY2024 | $1.8B | (1.19%) |
| FY2023 | $1.8B | 35.06% |
| FY2022 | $1.3B | (11.65%) |
| FY2021 | $1.5B | 61.24% |
| FY2020 | $921.0M | (9.79%) |
| FY2019 | $1.0B | (6.07%) |
| FY2018 | $1.1B | 22.27% |
| FY2017 | $889.0M | 12.11% |
| FY2016 | $793.0M | 54.88% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jul 2026 | $519.0M | 87.36% |
| Apr 2026 | $277.0M | 3.36% |
| Jan 2026 | $268.0M | (50.83%) |
| Oct 2025 | $545.0M | 50.55% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.7B |
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| A Agilent Technologies, Inc. | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.2B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $460.6M |
| NTRA Natera, Inc. compare | $212.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement